Women whose breast cancers need estrogen to grow are often treated for five or more years with medications to lower estrogen production or block its effects. Broadly known as endocrine therapy, the ...

An enzyme called cyclin-dependent kinase 2 (CDK2) regulates the cell cycle and may have the potential to drive therapeutic ...

A follow-up of the ShortHER trial suggests tumor-infiltrating lymphocytes (TILs) can help identify patients who may benefit ...

21, 2025 -- The FDA has approved a new treatment for patients ... that have already been treated with hormone therapy and chemotherapy. Breast cancer is the most common cancer (after skin cancer ...

Jan. 22, 2025 — Despite significant therapeutic advances, breast cancer remains a leading cause of cancer-related death in women. Treatment typically involves surgery and follow-up hormone ...

Trial confirms elinzanetant's efficacy and safety in addressing vasomotor symptoms caused by adjuvant endocrine therapy in patients with hormone receptor–positive breast cancer. Alcohol was ...

This approval marks a significant advancement in the treatment of hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer. The efficacy of datopotamab ...

This therapy employs systemic administration of the tissue hormone interferon-I combined with local application of Imiquimod. This combination showed promising results in topically accessible tumors ...

The US Food and Drug Administration (FDA) has approved datopotamab deruxtecan for the treatment ... hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast ...

silicone breast implants are safe but know if it increases the risk of breast cancer. Hormonal Therapy For Stage 4 Breast Cancer: All You Need To Know Hormonal therapy doesn't have side effects ...